Lumen Bioscience logo

Lumen Bioscience

lumen.bio

Lumen Bioscience engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs, as well as ingredients for human and animal nutrition. Its platform is intended to make biologic medicines faster and less costly to develop and more accessible to patients.

Facts

HQ
Seattle
Sectors
Biotechnology Research
Founded
2017
Type
Corporation Seattle business license
Employees
104
Registered name
Lumen Bioscience Inc Seattle business license
Stage
Series C
Founders
Brian Finrow, Jim Roberts

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Lumen Bioscience

See all 11

Lumen Bioscience adds Jeff Raikes to board, promotes executives and secures $30M Series C extension led by WestRiver Group

Lumen Bioscience announced board and leadership changes—including Jeff Raikes joining as an independent director, promotions of Nhi Khuong and Kole Krieger, and appointment of David Saunders—and elected Erik Anderson as Vice Chairman. The company also closed an oversubscribed $30 million Series C extension led by WestRiver Group with participation from the Gates Foundation and several new investors to support its orally delivered biologics clinical pipeline.

A-Alpha Bio raises $20M Series A led by Madrona to expand Seattle lab and scale protein-discovery platform

University of Washington spinout A-Alpha Bio raised $20 million in Series A funding led by Madrona Venture Group to expand downtown Seattle lab space and grow its machine-learning team for its protein-discovery platform. The company combines computational tools and yeast-based experiments to generate large protein-interaction datasets used to predict therapeutic protein candidates for diseases including COVID-19.

People

  • Brian Finrow
    Brian Finrow Co-Founder and Chief Executive Officer
  • Jim Roberts Co-Founder and Chief Scientific Officer

Online

Questions about Lumen Bioscience

What is Lumen Bioscience?

Lumen Bioscience is a startup based in Seattle that engineers the edible algae spirulina to produce therapeutic proteins for orally delivered biologic drugs and ingredients for human and animal nutrition.

What has Lumen Bioscience been in the news for?

WestRiver Group reported in October 2025 that Lumen Bioscience promoted executives.

Who are the people behind Lumen Bioscience?

Brian Finrow is co-founder and chief executive officer of Lumen Bioscience. Jim Roberts is co-founder and chief scientific officer.

Who invested in Lumen Bioscience, and how much has it raised?

Members of Seattle Flow see Lumen Bioscience's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Lumen Bioscience based?

Lumen Bioscience is based in Seattle.

When was Lumen Bioscience founded?

Lumen Bioscience was founded in 2017.